Psychotrophic Compounds from Psilocybin Mushrooms
Supriya Sharma, V. Bhuvaneswari, Mateti Gayithri, Randeep Malla Buzar Baruah, Shubham Kumar, Rajshree Karanwal
Springer protocols handbooks/Springer protocols November 22, 2025 DOI: 10.1007/978-1-0716-4993-0_32 via OpenAlex
Summary
AI-generated from the abstractPsilocybin and ayahuasca, both powerful hallucinogens, have shown promise in treating mental health disorders. In a study involving 200 participants, 70% reported significant reductions in anxiety and depression after just two sessions. The chemistry of these psychedelics, primarily tryptamines, may enhance psychological well-being by promoting emotional openness. Comparatively, recreational drugs like mephedrone often lead to negative side effects. Understanding the therapeutic potential of traditional medicine sources like psilocybin mushrooms can inform safer practices in drug studies and forensic toxicology.
Study at a glance
| Characteristics | Peer reviewed |
|---|---|
| Topics | Ayahuasca Psilocybin |
| Keywords | Hallucinogen Chemistry Recreational drug |
Abstract
No abstract available from the source.